Inventor · disambiguated record
Stephen Malcolm Thom
Also filed as: THOM STEPHEN MALCOLM
16 granted patents·2 pending applications·65 citations·filing 2013–2020
91Inventor score
Top patents by PatentIndex Score
18 records- 0193US9481648B2Kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Nov 1, 2016·22 cites·24 claims
- 0290US10125100B2Kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Nov 13, 2018·6 cites·4 claims
- 0389US9751837B2Kinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Sep 5, 2017·6 cites·25 claims
- 0485US9790174B2Kinase inhibitorsRESPIVERT LTD·Filed 2016·Granted Oct 17, 2017·3 cites·2 claims
- 0583US9890185B2Urea derivatives useful as kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Feb 13, 2018·8 cites·18 claims
- 0683US9796742B2Kinase inhibitorsRESPIVERT LTD·Filed 2016·Granted Oct 24, 2017·2 cites·23 claims
- 0783US9701670B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Jul 11, 2017·10 cites·18 claims
- 0882US10435361B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2017·Granted Oct 8, 2019·3 cites·22 claims
- 0982US10392346B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2018·Granted Aug 27, 2019·2 cites·6 claims
- 1082US10072034B2Kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Sep 11, 2018·3 cites·23 claims
- 1169US10941115B2Kinase inhibitorsOXULAR ACQUISITIONS LTD·Filed 2019·Granted Mar 9, 2021·0 cites·17 claims
- 1256US2015210722A1Kinase inhibitorsRESPIVERT LTD·Filed 2013·Application pending·0 cites
- 1355US2015225373A1Kinase inhibitorsRESPIVERT LTD·Filed 2013·Application pending·0 cites
- 1451US10442828B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2018·Granted Oct 15, 2019·0 cites·9 claims
- 1548US9790209B2Kinase inhibitorsRESPIVERT LTD·Filed 2016·Granted Oct 17, 2017·0 cites·19 claims
- 1647US9732063B2Kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Aug 15, 2017·0 cites·21 claims
- 1745US9783556B2Kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Oct 10, 2017·0 cites·18 claims
- 1843US12390437B2Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune responseSITRYX THERAPEUTICS LTD·Filed 2020·Granted Aug 19, 2025·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →